The wide availability of the AditxtScore for COVID-19 will help us address those challenges by giving people the hard facts about their immune status, helping them to make informed decisions about immunization.” “A lot of the hesitancy we’re seeing is driven by misinformation, potential infection post vaccination, and uncertainty about individual risk. “While we have seen relatively strong vaccine uptake in Michigan, just under half of our population is still not vaccinated and vaccine hesitancy remains a significant challenge in our rural and urban areas,” says Samar Nasry, MD, internal medicine specialist and director of the Medical Care1 Urgent Care, Michigan. The level of precision in AditxtScore for COVID-19, along with its ability to measure the neutralizing activity of IgG, IgM and IgA isotopes, can provide clinicians with the data they need to understand the strength and quality of each individual’s immune response to COVID-19, whether through exposure and infection or vaccination. It also includes the ability to measure neutralizing antibodies, the subset of virus-specific antibodies that block infection by interfering with cell entry of virus particles.
GREAT LAKES MEDICAL LABORATORY FULL
This multi-multiplex approach to capturing the full spectrum of biomarkers associated with SARS-CoV-2 delivers a highly detailed snapshot of an individual’s immune response in a single test cycle. With so much uncertainty out there right now around a surge in breakthrough cases, we need to take the guesswork out of the equation especially for patients who are vulnerable and immunocompromised.”ĪditxtScore for COVID-19, which was first introduced in August 2020, differentiates itself from traditional antibody tests by delivering a detailed view of an individual’s immune response to multiple antigens associated with the SARS-CoV-2 virus. “What I did not expect was that after receiving an AditxtScore myself I would find that I have had low immune response, despite being vaccinated. “We were drawn to Aditxt initially because it has the most comprehensive COVID-19 immune testing solution available, allowing us to give people certainty about their individual immune response to COVID-19,” says Elizabeth Knisely, chief executive officer of GLML. The initiative is part of Aditxt’s ongoing effort to expand its immune monitoring network nationwide. Under the agreement, GLML will make the AditxtScore for COVID-19 available throughout its six physical locations and mobile units in select areas in Michigan. This makes it possible to assess the strength of an individual’s immune response to the SARS-CoV-2 virus. The AditxtScore for COVID-19 is a comprehensive immune response monitoring that tracks multiple combinations of antibody and neutralizing antibody responses against several different antigens. AditxtScore for COVID-19 is being offered in Great Lakes Medical Laboratory (GLML) locations, allowing Michiganders and their physicians to monitor and evaluate their COVID-19 immune response.
0 kommentar(er)
